Dolphin Medical Services CFO Lakshmi Sudha Madala Resigns, Company Issues Corrigendum
Dolphin Medical Services Limited issued a corrigendum to its 12th February, 2026 board meeting outcome, formally recording CFO Mrs. Lakshmi Sudha Madala's resignation. The resignation, effective from 12th February, 2026, was inadvertently omitted from the original BSE upload despite being accepted during the meeting. Mrs. Madala cited personal reasons for her departure and committed to ensuring smooth transition of responsibilities.
*this image is generated using AI for illustrative purposes only.
Dolphin Medical Services Limited has issued a corrigendum to the Bombay Stock Exchange regarding its board meeting outcome held on 12th February, 2026, formally recording the resignation of Chief Financial Officer Mrs. Lakshmi Sudha Madala. The company acknowledged that the CFO's resignation was inadvertently omitted from the original BSE listing centre upload despite being tendered and accepted during the board meeting.
CFO Resignation Details
The resignation became effective from 12th February, 2026, with Mrs. Madala citing personal reasons for her departure from the position. The board has formally acknowledged and accepted her resignation while placing on record its appreciation for the services rendered during her tenure.
| Parameter: | Details |
|---|---|
| Name: | Mrs. Lakshmi Sudha Madala |
| Position: | Chief Financial Officer |
| Effective Date: | 12th February, 2026 |
| Reason: | Personal reasons |
| Communication Date: | 30th March, 2026 |
Regulatory Compliance
The corrigendum was communicated to the BSE on 30th March, 2026, and includes all information required under SEBI Master Circular No. SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024. The company has provided comprehensive documentation including the resignation letter and detailed annexure as per regulatory requirements.
Transition Process
In her resignation letter, Mrs. Madala expressed gratitude to the board, leadership team, and colleagues for their trust and collaboration throughout her tenure. She committed to ensuring a smooth transition of responsibilities and providing necessary assistance to facilitate the handover process. The CFO acknowledged the collective dedication and professionalism of the team, expressing confidence in the company's continued growth under its capable leadership.
Company Response
Dolphin Medical Services Limited, headquartered in Hyderabad, has treated this as a formal correction to ensure complete transparency and regulatory compliance. The corrigendum forms an integral part of the official board meeting record and should be read in conjunction with the original outcome from 12th February, 2026.
Who will Dolphin Medical Services appoint as the new CFO and what timeline are they targeting for the replacement?
How might the delayed disclosure of the CFO resignation impact investor confidence and the company's stock performance?
What specific financial reporting challenges could Dolphin Medical Services face during this leadership transition period?
19
Access Market Heat-map & Insights 
Create, Save & Share your Screener 
Use 200+ Screening Filters 
